How One Pharma Used Connected Specialty Drug Data and RWD to Improve Patient Adherence
A top-20 pharmaceutical company found that a significant portion of patients on infusion therapy had discontinued treatment despite being enrolled in assistance programs. The company used Datavant Switchboard to connect specialty pharmacy data and patient-hub information with real-world data sources to investigate the discontinuation problem. The landing page frames this as enabling identification of and response to patient adherence challenges, but does not itself disclose specific outcome metrics -- those are noted as being in a downloadable case study PDF not accessible via this fetch.
Datavant is the tokenization and linkage infrastructure behind most of the US real-world-data ecosystem — it de-identifies and connects patient records across health-data partners without exposing PII.
This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.
Published by Datavant on its own site — read the original case study on datavant.com ↗
Related use cases
- 01Trial Tokenization and Linking to Real World Data: Extending the effectiveness and safety analysis of a new focal seizure treatment
- 02Profiling and Diagnosing Rare Disease Patients
- 03Case Study: The power of patient matching in real-world data
- 04Research Using Health Data Connected by Datavant
- 05Building a Trusted Partnership for Coding Excellence with Southwest General Health Center
- 06The Picture Comes into Focus for Patients Suffering with Rare Eye Disease